Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study

被引:0
作者
Sana, Adama [1 ]
Djemai, Elodie [2 ]
De Vreyer, Philippe [2 ]
Thivillon, Thomas [3 ]
Badolo, Hermann [4 ]
Berthe, Abdramane [5 ,6 ]
Kania, Dramane [6 ]
机构
[1] Ctr Natl Rech Sci & Technol CNRST, Inst Rech Sci Sante IRSS, Dept Biomed & Sante Publ, Ouagadougou, Burkina Faso
[2] Univ PSL, Univ Paris Dauphine, LEDa, CNRS,IRD,DIAL, Paris, France
[3] Univ Bordeaux, UMR, Bordeaux Sci Econ, CNRS 6060, Pessac, France
[4] Inst Natl Sante Publ, Observ Natl Sante Populat, Ouagadougou, Burkina Faso
[5] Univ Dedougou, Dedougou, Burkina Faso
[6] Inst Natl Sante Publ, Ctr Muraz, Bobo Dioulasso, Burkina Faso
来源
PLOS ONE | 2024年 / 19卷 / 08期
关键词
AFRICAN COUNTRIES; PERFORMANCE; COVID-19;
D O I
10.1371/journal.pone.0305850
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Since March 2020, COVID-19 has evolved from a localized outbreak to a global pandemic. We assessed the seroprevalence of COVID-19 in three towns in the Centre Sud region of Burkina Faso.Methods A population-based cross-sectional survey was conducted in three middle-sized cities in Burkina Faso's Centre Sud region, from June to July 2021. Subjects aged 16 or over at the time of the survey were considered for this seroprevalence study. The Biosynex COVID-19 BSS rapid test was used to detect immunoglobulin G (IgG) and immunoglobulin M (IgM) against SARS-CoV-2. A standardized questionnaire was also administered to collect additional information.Results A total of 2449 eligible participants (age >= 16 years) were identified. Serological tests for COVID-19 were performed in 2155 individuals, of which 2143 valid tests were retained and analyzed. Out of the entire sample, 246 positive tests were observed, corresponding to a prevalence of 11.48%. Prevalence was 9.35% (58 cases) in Kombissiri, 12.86% (80 cases) in Manga and 11.99% (108 cases) in P & ocirc;. By gender, 13.37% of women (164 cases) tested positive, and 8.95% of men (82 cases). Women accounted for 66.67% of all positive test subjects. The results from the multivariate analysis show a significantly higher seroprevalence in women (p = 0.007), people over 55 years old (p = 0.004), overweight people (p = 0.026) and those with drinking water sources at home (p = 0.013).Conclusions The results of this study show that the COVID-19 virus also circulates in the population of middle-sized cities in Burkina Faso, far more than officially reported by the information service of the government of Burkina Faso, given the lack of systematic testing in the general population in the country. The study also highlighted the greater vulnerability of women, older and overweight individuals to the epidemic. The preventive measures put in place to fight the pandemic must take these different factors into account.
引用
收藏
页数:17
相关论文
共 49 条
  • [1] [Anonymous], 2022, Cinquieme Recensement General de la Population et de lHabitation du Burkina Faso, Synthese des resultats definitifs, Ouagadougou, INSD, 2e edition
  • [2] [Anonymous], Rapport de situation de l'evaluation de la COVID-19 au Burkina Faso
  • [3] Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study
    Beaumont, Adeline
    Durand, Cecile
    Ledrans, Martine
    Schwoebel, Valerie
    Noel, Harold
    Le Strat, Yann
    Diulius, Donatien
    Colombain, Lea
    Medus, Marie
    Gueudet, Philippe
    Mouly, Damien
    Aumaitre, Hugues
    [J]. BMJ OPEN, 2021, 11 (11):
  • [4] Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
    Bobrovitz, Niklas
    Arora, Rahul Krishan
    Cao, Christian
    Boucher, Emily
    Liu, Michael
    Donnici, Claire
    Yanes-Lane, Mercedes
    Whelan, Mairead
    Perlman-Arrow, Sara
    Chen, Judy
    Rahim, Hannah
    Ilincic, Natasha
    Segal, Mitchell
    Duarte, Nathan
    Van Wyk, Jordan
    Yan, Tingting
    Atmaja, Austin
    Rocco, Simona
    Joseph, Abel
    Penny, Lucas
    Clifton, David A.
    Williamson, Tyler
    Yansouni, Cedric P.
    Evans, Timothy Grant
    Chevrier, Jonathan
    Papenburg, Jesse
    Cheng, Matthew P.
    [J]. PLOS ONE, 2021, 16 (06):
  • [5] Bolay J.-C., 2015, Current Urban Studies, V3, P413, DOI [DOI 10.4236/CUS.2015.34033, 10.4236/cus.2015.34033]
  • [6] The Determinants of the Low COVID-19 Transmission and Mortality Rates in Africa: A Cross-Country Analysis
    Bouba, Yagai
    Tsinda, Emmanuel Kagning
    Fonkou, Maxime Descartes Mbogning
    Mmbando, Gideon Sadikiel
    Bragazzi, Nicola Luigi
    Kong, Jude Dzevela
    [J]. FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [7] Burkina Faso, 2014, Enquete Multisectorielle Continue 2014
  • [8] The COVID-19 pandemic in the African continent
    Bwire, Godfrey
    Ario, Alex Riolexus
    Eyu, Patricia
    Ocom, Felix
    Wamala, Joseph F.
    Kusi, Kwadwo A.
    Ndeketa, Latif
    Jambo, Kondwani C.
    Wanyenze, Rhoda K.
    Talisuna, Ambrose O.
    [J]. BMC MEDICINE, 2022, 20 (01)
  • [9] The Fight Against Severe COVID-19: Can Parasitic Worms Contribute?
    Cai, Pengfei
    Mu, Yi
    McManus, Donald P.
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Old friends meet a new foe A potential role for immune-priming parasites in mitigating COVID-19 morbidity and mortality
    Cepon-Robins, Tara J.
    Gildner, Theresa E.
    [J]. EVOLUTION MEDICINE AND PUBLIC HEALTH, 2020, (01) : 234 - 248